{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/leg-ulcer-venous/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"38f24092-0019-582d-86bf-d1f61bccde1d","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field b38ef5f8-3f20-4b6f-9160-809e1fa77fa2 --><h2>Changes</h2><!-- end field b38ef5f8-3f20-4b6f-9160-809e1fa77fa2 -->","summary":null,"htmlStringContent":"<!-- begin item c74e62eb-4843-4656-b589-2559bd06429e --><!-- begin field 9614c39f-ab1f-4f87-bd71-307c0cefff92 --><p><strong>January 2021</strong> — minor update. Contraindications and drug interactions for erythromycin have been updated in line with an MHRA drug safety update. </p><!-- end field 9614c39f-ab1f-4f87-bd71-307c0cefff92 --><!-- end item c74e62eb-4843-4656-b589-2559bd06429e -->","topic":{"id":"627b2b3c-014b-5543-8f89-0f3ffa6344ad","topicId":"4c5db985-9544-48b2-8c54-8915ec210739","topicName":"Leg ulcer - venous","slug":"leg-ulcer-venous","lastRevised":"Last revised in January 2021","chapters":[{"id":"01818c5e-efb9-59c4-b339-08b834294232","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"313e84c5-8bc7-5150-826a-467ea7252acd","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"2597db24-8ec5-54d4-86ad-8082be50f4f6","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"38f24092-0019-582d-86bf-d1f61bccde1d","slug":"changes","fullItemName":"Changes"},{"id":"cdc15e74-0503-53a5-a4be-c53ec4e20898","slug":"update","fullItemName":"Update"}]},{"id":"73d0cf59-f9c0-5785-8c74-e756826d5d1e","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"64b11689-d52a-560f-8d9b-c592d654615e","slug":"goals","fullItemName":"Goals"},{"id":"ac3d1637-467f-5edb-8fd8-73f66160080f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"4bffe5b2-0ce0-5ae8-8c0b-914bb6ed5a1d","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"82441da5-60f5-53b4-b510-187f7bacb4a8","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"3e5817d5-30e7-54b7-b9ba-224b4a295bba","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b30bb006-efbc-5a69-90f3-30abf232a97d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"84dc0da0-8533-5c5d-99f6-7c04a116701a","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"45d8d35d-9757-544c-b04e-9747898a1f0e","slug":"definition","fullItemName":"Definition"},{"id":"21acb832-e5e8-5bd1-9b8d-9410ec5011bf","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"cf27bd7b-b787-5def-bb40-ee0f134a8aca","slug":"prevalence","fullItemName":"Prevalence"},{"id":"a55a1739-f3d2-534c-b533-f6406d9c81ea","slug":"complications","fullItemName":"Complications"},{"id":"683b612a-3f1d-5580-951b-e14672f52b4a","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"dbc94220-a914-56d0-883d-d158da511e1c","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"57b3b7a5-9042-53fa-a236-56d0d02b647e","slug":"assessment","fullItemName":"Assessment"},{"id":"35ee8784-602e-5a29-9ccf-65b3c3f940d2","slug":"interpretation-of-abpi","fullItemName":"Interpretation of ABPI"},{"id":"0c766f2c-0c8f-521b-85fd-e947ba6b2d09","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"5e199f8a-7621-5318-9da1-264db8f544b8","fullItemName":"Management","slug":"management","subChapters":[{"id":"c8bda10b-ebb6-533b-9c91-96efa5ddf0c3","slug":"venous-leg-ulcers","fullItemName":"Scenario: Venous leg ulcers"}]},{"id":"e084faba-a409-53ac-aa53-08b80a3991f1","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"66a7f656-c6f5-57a2-a08a-1533a6fd4e92","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"a6cda703-9039-5115-b3d3-478cdb4d1e55","slug":"co-amoxiclav","fullItemName":"Co-amoxiclav"},{"id":"1cf75cbb-8bc4-58cc-9a1b-11516db5ad2c","slug":"co-trimoxazole","fullItemName":"Co-trimoxazole"},{"id":"3f0efc32-779b-56f6-85ca-e46a59745bed","slug":"doxycycline","fullItemName":"Doxycycline"},{"id":"fe306aab-d8d7-5181-a461-128f2aa3c65a","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"314a80d5-e16b-5625-8d64-4141535ff392","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"b7e7b8ec-799c-5ea5-9ac0-11935f899b8a","slug":"oral-analgesia","fullItemName":"Oral analgesia"},{"id":"43ed3b03-6322-5690-8f85-b6e10a0b3d3e","slug":"pentoxifylline","fullItemName":"Pentoxifylline"}]},{"id":"19f3ffbe-f365-5196-8586-0dceeaf69908","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"89207239-b8a4-50ce-8b2d-3065a830c0af","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"45831e7c-0e6f-50f3-a513-fe4fcacff65e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3d90cdb0-b2fd-5bfd-bd2d-342e36901f9d","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"8b66d1a4-6ee5-5556-b671-204219a81787","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"5b8ee442-8da6-524f-bf34-e6a9cc2a771e","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6fa96be3-beae-51f6-9f1c-4d278b058d09","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"e75dc366-237b-55d2-a654-2e3bf503b955","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"2597db24-8ec5-54d4-86ad-8082be50f4f6","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"ead1ef62-4a47-5855-9938-93e7c186ffaf","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field 576a7650-b657-4001-a0b8-36ada7d6ef46 --><h3>Previous changes</h3><!-- end field 576a7650-b657-4001-a0b8-36ada7d6ef46 -->","summary":null,"htmlStringContent":"<!-- begin item db6d3875-9e81-453d-9e6d-d8c51334ea77 --><!-- begin field 6e4ee58d-36be-4d28-8cd4-16edf18846bc --><p><strong>October 2020 </strong>— minor update. A typographical error has been corrected.</p><p><strong>February 2020</strong> — minor update. Topic updated in line with NICE guideline, NG152 <em>Leg ulcer infection: antimicrobial prescribing </em>[NICE, 2020].</p><p><strong>July 2019</strong> — reviewed. A literature search was conducted in June 2019 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of this topic. The recommendations on managing an infected leg ulcer have been changed in line with the National Institute for Health and Care Excellence (NICE) <em>Draft guideline on leg ulcer infection: antimicrobial prescribing </em>[NICE, 2019]. The scope of the topic has been clarified, and the topic has been restructured. </p><p><strong>April 2017 </strong>— minor update. Update to incorporate feedback from the Venous Forum of the Royal Society of Medicine.</p><p><strong>October to November 2015</strong> — reviewed. A literature search was conducted in October 2015 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last version of this topic. </p><ul><li>A recommendation to consider prescribing pentoxifylline to improve ulcer-healing rates has been added to reflect clinical guidance in the Scottish Intercollegiate Guidelines Network (SIGN) guideline <em>Management of chronic venous leg ulcers </em>[SIGN, 2010] and a Cochrane systematic review<img> [July, 2015].</li><li>The definition of leg ulcer has been updated, in line with the NICE guideline <em>Varicose veins in the legs: The diagnosis and management of varicose veins </em>[NICE, 2013].</li><li>A recommendation to refer people with venous leg ulcer for specialist advice after two weeks of primary care treatment was added, in line with the NICE guideline <em>Varicose veins in the legs: The diagnosis and management of varicose veins </em>[NICE, 2013].</li><li>The recommendation to consider prescribing erythromycin for infected leg ulcer has been removed in line with current prescribing guidelines and good clinical practice. </li><li>The topic has undergone minor restructuring, and prescribing information sections for the recommended antibiotics have been added.</li></ul><p><strong>July 2015</strong> — minor update. The information on the concurrent use of clarithromycin or erythromycin with statins has been clarified.</p><p><strong>April 2015</strong> — minor update. Link inserted to the CKS topic on Analgesia - mild-to-moderate pain.</p><p><strong>September 2012</strong> — reviewed. A literature search was conducted in September 2012 to identify evidence-based guidelines, UK policy, systematic reviews, and key RCTs published since the last revision of the topic. No changes to clinical recommendations have been made.</p><p><strong>June 2012</strong> — minor update. Minor typographical error corrected. </p><p><strong>March 2011</strong> — topic structure revised to ensure consistency across CKS topics — no changes to clinical recommendations have been made. </p><p><strong>September 2010</strong> — minor update. Text updated to include recommendations from the Scottish Intercollegiate Guidelines Network guideline <em>Management of chronic venous leg ulcers.</em></p><p><strong>November 2008</strong> — minor update. Rewording of text regarding prescribing erythromycin or clarithromycin for people with penicillin allergy. Issued in December 2008. </p><p><strong>November 2007 to February 2008</strong> — converted from CKS guidance to CKS topic structure. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence. There are no major changes to the recommendations. </p><p><strong>January 2007</strong> — antibiotic prescriptions for infected leg ulcers updated. Issued in January 2007. </p><p><strong>October 2005</strong> — minor technical update. Issued in November 2005. </p><p><strong>August 2004</strong> — written. Validated in September 2004 and issued in November 2004.</p><!-- end field 6e4ee58d-36be-4d28-8cd4-16edf18846bc --><!-- end item db6d3875-9e81-453d-9e6d-d8c51334ea77 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}